Xuefeng Leng

1.1k total citations
76 papers, 384 citations indexed

About

Xuefeng Leng is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xuefeng Leng has authored 76 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Surgery, 55 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in Xuefeng Leng's work include Esophageal Cancer Research and Treatment (52 papers), Gastric Cancer Management and Outcomes (34 papers) and Esophageal and GI Pathology (29 papers). Xuefeng Leng is often cited by papers focused on Esophageal Cancer Research and Treatment (52 papers), Gastric Cancer Management and Outcomes (34 papers) and Esophageal and GI Pathology (29 papers). Xuefeng Leng collaborates with scholars based in China, United States and Japan. Xuefeng Leng's co-authors include Yongtao Han, Wenwu He, Lin Peng, Lei Xian, Qiang Fang, Manhong Li, Lei Dai, Vinodh Kannappan, Jinping Zhang and Guangyao Ma and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Xuefeng Leng

58 papers receiving 379 citations

Peers

Xuefeng Leng

PRM

SURGE

ONCOL

Yeong‐Chin Jou Taiwan

Abdulmajeed Aydh Austria

Maximilian Pallauf Austria

Özlem Erçelep Türkiye

Joseph Song United States

Toyofusa Tobe Japan

Audrey Rhee United States

Shun Ishiyama Japan

Wanlim Kim South Korea

Yeong‐Chin Jou Taiwan

Xuefeng Leng

225 ×1.2

PRM

112 ×0.6

SURGE

154 ×1.6

66 ×0.8

ONCOL

50 ×0.9

Citations per year, relative to Xuefeng Leng Xuefeng Leng (= 1×) peers Yeong‐Chin Jou

Countries citing papers authored by Xuefeng Leng

Since Specialization

Citations

This map shows the geographic impact of Xuefeng Leng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Leng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Leng more than expected).

Fields of papers citing papers by Xuefeng Leng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefeng Leng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Leng. The network helps show where Xuefeng Leng may publish in the future.

Co-authorship network of co-authors of Xuefeng Leng

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Leng. A scholar is included among the top collaborators of Xuefeng Leng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Leng. Xuefeng Leng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Wenwu, Hansong Bai, Peng Tang, et al.. (2025). Neoadjuvant chemotherapy or chemoradiotherapy plus sintilimab versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a study protocol of a multicentre, randomised, controlled, phase III trial (SCIENCE study). BMJ Open. 15(6). e095828–e095828.

Huang, Guiyu, Jie Zhu, Ben He, et al.. (2025). Prognostic Impact of Sarcopenia and Surgical Timing in Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy: TIMES Study. Annals of Surgical Oncology. 32(6). 4140–4150. 1 indexed citations

Qian, Jingjing, et al.. (2025). Digital economy and corporate total factor productivity: evidence from China. Applied Economics Letters. 1–7.

He, Wenwu, Chunyan Luo, Yan Xia, et al.. (2024). Longitudinal patient-reported outcomes after minimally invasive McKeown esophagectomy for patients with esophageal squamous cell carcinoma. Supportive Care in Cancer. 32(4). 237–237. 3 indexed citations

Li, Kexun, Ziwei Wang, Wenwu He, et al.. (2024). Comparative analysis of manual vs. mechanical suturing techniques in esophagectomy: A propensity score‑matched study of long‑term outcomes. Oncology Letters. 29(1). 51–51.

Li, Kexun, Wenwu He, Chenghao Wang, et al.. (2024). Long-term outcomes of intrathoracic versus cervical anastomosis after esophagectomy: A large-scale propensity score matching analysis. Journal of Thoracic and Cardiovascular Surgery. 170(2). 391–404.e2.

Wei, Xing, Qiuling Shi, Qiang Zhou, et al.. (2024). Enhanced Recovery Protocol Versus Conventional Care in Patients Undergoing Esophagectomy for Cancer: Advantages in Clinical and Patient-Reported Outcomes. Annals of Surgical Oncology. 31(9). 5706–5716. 4 indexed citations

Wang, Yi, Lei Wu, Gang Wan, et al.. (2024). Neoadjuvant chemoradiotherapy for T3N0M0 esophageal squamous cell carcinoma. 2(3). 3821–3821.

Li, Jiang, Xue Chen, Yi Wang, et al.. (2024). Reduction in chemotherapy relative dose intensity decreases overall survival of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal carcinoma. BMC Cancer. 24(1). 945–945. 3 indexed citations

10.

Daiko, Hiroyuki, Koshiro Ishiyama, Daisuke Kurita, et al.. (2024). Technical feasibility and oncological outcomes of robotic esophagectomy compared with conventional thoracoscopic esophagectomy for clinical T3 or T4 locally advanced esophageal cancer: a propensity-matched analysis. Surgical Endoscopy. 38(7). 3590–3601. 5 indexed citations

11.

Li, Kexun, Wenwu He, Kun Liu, et al.. (2024). Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival Analysis. Annals of Surgical Oncology. 31(6). 3794–3802. 6 indexed citations

12.

Zhou, Qiang, Qiao He, Wenwu He, et al.. (2023). Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study. BMC Cancer. 23(1). 1171–1171. 1 indexed citations

13.

Li, Kexun, Kun Liu, Wenwu He, et al.. (2023). Impact of two‑field or three‑field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysis. Oncology Letters. 25(5). 189–189. 11 indexed citations

14.

Leng, Xuefeng, Daisuke Kurita, Yi Zhu, et al.. (2023). Collaborative multidisciplinary management and expertise of cT2–3 locally advanced operable esophageal squamous cell carcinoma: a report of two cases. Journal of Thoracic Disease. 15(11). 6362–6372. 1 indexed citations

15.

Leng, Xuefeng, et al.. (2023). Utility of G protein-coupled oestrogen receptor 1 as a biomarker for pan-cancer diagnosis, prognosis and immune infiltration: a comprehensive bioinformatics analysis. Aging. 15(21). 12021–12067. 1 indexed citations

16.

Leng, Xuefeng, Bo Wang, Hanlin Zhang, et al.. (2022). Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials. Frontiers in Immunology. 13. 1041233–1041233. 8 indexed citations

17.

Li, Jiang, Xue Chen, Yi Wang, et al.. (2022). Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study. Radiation Oncology. 17(1). 218–218. 3 indexed citations

18.

Wang, Kangning, Kai Xu, Xuefeng Leng, Yongtao Han, & Qiang Fang. (2020). miRNA-9 Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Regulating NRSF/EGFR. Technology in Cancer Research & Treatment. 19. 1079213455–1079213455. 10 indexed citations

19.

Leng, Xuefeng, et al.. (2017). Case report of a ganglioneuroma with metaplasia by adipocytes: use of a multi-disciplinary team as a key aid in difficult diagnosis and combined surgery. Translational Cancer Research. 6(2). 457–462. 2 indexed citations

20.

Kannappan, Vinodh, et al.. (2016). RBP2 induces stem-like cancer cells by promoting EMT and is a prognostic marker for renal cell carcinoma. Experimental & Molecular Medicine. 48(6). e238–e238. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact